Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
8
×
life sciences
national blog main
new york blog main
8
×
raleigh-durham blog main
8
×
san diego blog main
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
biotech
boston blog main
detroit blog main
detroit top stories
national top stories
new york top stories
raleigh-durham top stories
san diego top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
indiana blog main
indiana top stories
national
cancer immunotherapy
europe blog main
europe top stories
fda
merck
pfizer
alzheimer's disease
amag pharmaceuticals
astrazeneca
gilead sciences
What
bio
roundup
develop
sciences
acquisitions
amid
bombast
buy
cancer
caught
ceo
coronavirus
daniel
deal
debate
discussion
efforts
gilead
help
life
meso’s
miss
o’day
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
years
adding
admits
ago
aims
alliance
announced
bails
big
Language
unset
8
×
Current search:
deals
×
" raleigh-durham blog main "
×
unset
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In